ASBP
NASDAQ
$6.58
Aspire Biopharma Holdings Inc (ASBP)
Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$9.03M
Free Cash Flow Yield
-68.78%
Beta (5Y)
1.63
Price Chart
Valuation
Market Cap$9.03M
P/S226.40
P/B2.02
Profitability
Total Revenue (TTM)$35K
Gross Profit (TTM)$5.63K
EBITDA$4.28M
Operating Margin-5759%
EPS-$8.41
Financial Health
Debt-to-Equity38.8%
Free Cash Flow Yield-68.78%
Growth & Risk
Beta (5Y)1.63
Sharpe Ratio-0.94